EUVIMEDEUVIMED entdecken
Crossref

Vitamin D supplementation could enhance the effectiveness of glibenclamide in treating type 2 diabetes by improving the function of pancreatic β-cells through the NF-κB pathway

Ruimin Jia, Liting Liang, Yongkai Yin, Changmiao Niu, Xingmei Zhao, Xue Shuwen, Mingzhi Zhang, Xiaoning Yan

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Ruimin Jia und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Shanxi University of Chinese Medicine, No. 121, Daxue Street, Higher Education Park, Jinzhong City, Shanxi Province, 030619, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Dietary Supplements, Glyburide, Insulin-Secreting Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The high morbidity and mortality associated with type 2 diabetes mellitus (T2DM) pose a significant global health challenge, necessitating the development of more efficient anti-diabetic drugs with fewer side effects. This study investigated the intervention of vitamin D3 combined with glibenclamide in rats with T2DM to elucidate its effects on pancreatic β-cells through the NF-κB pathway. METHODS: Twenty-four healthy male Sprague-Dawley (SD) rats were randomly assigned to four groups: the control group (CG), the model group (MG), the glibenclamide group (GG), and the glibenclamide + vitamin D3 group (GDG). After inducing the T2DM model using high-fat and high-sugar diet and intraperitoneal injection of streptozotocin, the rats in the GG group were administered glibenclamide orally (0.6 mg/kg/day), while those in the GDG group received both glibenclamide (0.6 mg/kg/day) and vitamin D3 (500 IU/kg/day) in corn oil for a duration of 8 weeks. Biochemical indices were measured, and histopathological changes in pancreatic tissue and islet β cells were observed using hematoxylin and eosin staining. The expression of pancreatic nuclear factor κB (NF-κB), islet β-cells, and inflammatory cytokines were assessed using the TUNEL method and PCR. RESULTS: According to the data from this current study, the GDG group showed significant positive differences in plasma biochemical indices, as well as in the expression of β cells, NF-κB p65, TNF-α, IL-1β, INF-γ, and Fas, compared to the GG and CG groups (P < 0.05). CONCLUSION: The results suggest that vitamin D has beneficial effects on T2DM by improving the functions of islet β cells through inhibition of the NF-κB signaling pathway. Therefore, it is suggested that vitamin D supplementation, when used alongside antidiabetic drugs, may more effectively prevent and treat T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Dietary SupplementsGlyburideInsulin-Secreting CellsNF-kappa BRats, Sprague-DawleySignal TransductionAnimalsMaleRatsDiabetes Mellitus, ExperimentalHypoglycemic AgentsVitamin D

Stichwörter der Autor:innen

GlibenclamideNF-κBPancreatic β-cellsType 2 diabetesVitamin D

Substanzen

GlyburideHypoglycemic AgentsNF-kappa BVitamin D

Autor:innen und Institutionen

  • School of Nursing, Shanxi University of Chinese Medicine, No. 121, Daxue Street, Higher Education Park, Jinzhong City, Shanxi Province, 030619, China.
  • Graduate School of Shanxi University of Chinese Medicine, No. 121, Daxue Street, Higher Education Park, Jinzhong City, Shanxi Province, 030619, China.
  • Graduate School of Shanxi University of Chinese Medicine, No. 121, Daxue Street, Higher Education Park, Jinzhong City, Shanxi Province, 030619, China. Electronic address: yanxn@sxtcm.edu.cn.

Zitieren

APA

Jia, R., Liang, L., Yin, Y., Niu, C., Zhao, X., Shuwen, X., Zhang, M., & Yan, X. (2024). Vitamin D supplementation could enhance the effectiveness of glibenclamide in treating type 2 diabetes by improving the function of pancreatic β-cells through the NF-κB pathway. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150596

Vancouver

Jia R, Liang L, Yin Y, Niu C, Zhao X, Shuwen X, et al. Vitamin D supplementation could enhance the effectiveness of glibenclamide in treating type 2 diabetes by improving the function of pancreatic β-cells through the NF-κB pathway. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150596

BibTeX
@article{Jia2024,
  author = {Jia, Ruimin and Liang, Liting and Yin, Yongkai and Niu, Changmiao and Zhao, Xingmei and Shuwen, Xue and Zhang, Mingzhi and Yan, Xiaoning},
  title = {Vitamin D supplementation could enhance the effectiveness of glibenclamide in treating type 2 diabetes by improving the function of pancreatic β-cells through the NF-κB pathway},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150596}
}
Kostenlos starten →